Here are five things to know:
1. Researchers are continually devising new technology to improve patient outcomes, thereby fueling market growth.
2. However, a lack of health infrastructure and awareness about eye disorders as well as inadequate primary healthcare infrastructure may impede market growth.
3. North America holds the largest market share, with 24.2 million Americans having a cataract diagnosis.
4. Companies operating in the market include:
• Carl Zeiss Meditech in Jena, Germany
• Abbott Laboratories in Chicago
• Alcon in Fort Worth, Texas
• Allergan in Parsippany-Troy Hills, N.J.
• Bausch & Lomb in Rochester, N.Y.
• Essilor International in Charenton-le-Pont, France
• Opcon Corp. in Kyoto, Japan
• NIDEK Co. in Aichi, Japan
• STAAR Surgical Co. in Monrovia, Calif.
More articles on healthcare:
14 healthcare thought leaders on President Trump’s executive order on the ACA
Dr. Russell Howerton, Hologic’s Kathleen Troeger join PCORI governing board
AGA, partners a step closer to developing CME to improve IBD management
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
